Evidence map›Paper›PMID 29923037›Full record

ArticleNeurochemical research2018

Different Characteristics of Hepcidin Expression in IL-6+/+ and IL-6-/- Neurons and Astrocytes Treated with Lipopolysaccharides.

Juan Ma, Fa-Li Zhang, Gan Zhou, Yu-Xin Bao, Yuan Shen, Zhong-Ming Qian

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Inflaming the Brain with Iron.Antioxidants (Basel, Switzerland) · 2021
    Review
  7. Article
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Juan MaLaboratory of Neuropharmacology, Fudan University School of Pharmacy, 826 Zhang Heng Road, Shanghai, 201203, People's Republic of China.
Fa-Li ZhangLaboratory of Neuropharmacology, Fudan University School of Pharmacy, 826 Zhang Heng Road, Shanghai, 201203, People's Republic of China.
Gan ZhouDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China. ganzhou_cs@163.com.
Yu-Xin BaoResearch Center for Medicine and Biology, Zunyi Medical University, Zunyi, 563000, Guizhou, People's Republic of China. baoyuxin8680915@126.com.
Yuan ShenLaboratory of Neuropharmacology, Fudan University School of Pharmacy, 826 Zhang Heng Road, Shanghai, 201203, People's Republic of China.
Zhong-Ming QianLaboratory of Neuropharmacology, Fudan University School of Pharmacy, 826 Zhang Heng Road, Shanghai, 201203, People's Republic of China. qianzhongming@fudan.edu.cn.
Fudan University · CNCentral South University · CNNantong University · CNZunyi Medical University · CN

Funding

National Natural Science Foundation of China 31330035National Natural Science Foundation of China 31571195
6 · The paper itself

Abstract

A region-specific regulation of inflammation on the expression hepcidin in the brain has been demonstrated, however, it remains unknown whether there is also a cell-specific regulation of inflammation on hepcidin in the brain. Here, we investigated the effects of lipopolysaccharides (LPS) on the expression of hepcidin mRNA and also the expression of IL-6 mRNA, the phosphorylation of STAT3 and the expression of ferroportin 1 (Fpn1) and ferritin light chain (Ft-L) proteins in neurons and astrocytes obtained from wild type (IL-6+/+) and IL-6 knockout (IL-6-/-) mice. We demonstrated that the responses of the expression of hepcidin and IL-6 mRNAs, the phosphorylation of STAT3, and the expression of Fpn1 protein to LPS in IL-6+/+ astrocytes and also the responses of the expression of hepcidin mRNA, the phosphorylation of STAT3 and the expression of Fpn1 protein to IL-6 in IL-6-/- astrocytes were much stronger than those in IL-6+/+ and IL-6-/- neurons. A significant increase in Ft-L was found in LPS-treated IL-6+/+ and IL-6-treated IL-6-/- astrocytes, but not in LPS-treated IL-6+/+ and IL-6-treated IL-6-/- neurons. Our findings provide in vitro evidence for the existence of a cell-specific regulation of LPS on the expression of hepcidin and also Ft-L in the brain.

Indexed as

AnimalsApoferritinsAstrocytesCation Transport ProteinsFerroportinGene Knockout TechniquesHepcidinsInterleukin-6LipopolysaccharidesMaleMice, Inbred C57BLNeuronsSTAT3 Transcription FactorApoferritinsCation Transport ProteinsFerroportinHepcidinsInterleukin-6interleukin-6, mouseLipopolysaccharidesStat3 protein, mouseSTAT3 Transcription FactorFerritin light chain (Ft-L) and cell iron contentHepcidin and ferroportin 1 (Fpn1)IL-6/STAT3 pathwayLipopolysaccharides (LPS)Neuron and astrocyte

Identifiers

PMID29923037
OpenAlexW2808766864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.